The FTC report said the companies responsible for controlling spending on drugs were sometimes steering patients toward more expensive medicines.
Related Posts
SEC Accuses Carl Icahn of Concealing Stock Pledges
Activist investor Icahn agrees to pay $500,000 and his company will pay $1.5 million, without admitting or denying SEC findings.
BNP Paribas Confirms Outlook After Strong Second Quarter
BNP Paribas backed its guidance for the year after posting better-than-expected earnings for the second quarter, with double-digit growth in its institutional banking and capital […]
Commerzbank Confirms Independent Strategy Ahead of Talks With UniCredit
The German lender said it planned to improve its profitability and boost shareholder returns as it grapples with a possible takeover attempt by Italy’s UniCredit.